Development of an ELISA-Based Pulldown Approach for Functional Analysis of Antigen-Specific Antibodies
Steventon, R.; Stolle, L.; Gregory, R.; Gaetani, L.; Carnell, G. W.; McInally, C.; Jarvis, L.; Temperton, N.; Thompson, C. P.
Show abstract
The identification of antigen-specific neutralising antibodies is essential for vaccine development and therapeutic discovery, yet current methods either lack functional readouts or are impractical for polyclonal sera from large cohorts. Here, we describe an ELISA-based pulldown methodology that isolates functional antibodies from serum samples while preserving their neutralising activity for downstream applications. We optimised elution conditions using 3M MgCl2 in HEPES buffer, which effectively disrupts antibody-antigen interactions without dislodging immobilised antigen or impairing antibody function. The assay demonstrated 100% specificity and 77.78% sensitivity for detecting known positive samples. Compatibility with pseudotype neutralisation assays was established, with maximum tolerable MgCl2 concentrations defined for direct use without dialysis. As proof-of-concept, we applied the method to identify domain-specific neutralising antibodies against the influenza virus haemagglutinin, distinguishing head-targeting from stem-targeting responses in human sera. This methodology provides a scalable platform for dissecting functional antibody responses with epitope-level resolution. HighlightsO_LIAdapted ELISA pulldown isolates functional antigen-specific antibodies C_LIO_LI3M MgCl2 elution preserves antibody functionality C_LIO_LICompatible with Influenza pseudotype neutralisation assays C_LIO_LIAllows for the identification of region-specific antibodies C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=128 SRC="FIGDIR/small/706726v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@1ab9bforg.highwire.dtl.DTLVardef@98e20borg.highwire.dtl.DTLVardef@120687dorg.highwire.dtl.DTLVardef@abf267_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Adaption of a Conventional ELISA to a 96-well ELISA-Array for Measuring the Antibody Responses to Influenza virus proteins, viruses and vaccines 96%
- Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples 94%
- Multiplex ACE2-RBD Binding Inhibition Assay: An Integrated Tool for Assessing Neutralizing Antibodies to SARS-CoV-2 Variants and Protection against Breakthrough Infections 94%
Similar papers in this journal
Similar papers in this journal
- Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening 96%
- SARS-CoV2 mutant-specific T cells and neutralizing antibodies after vaccination and up to 1 year after infection 94%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 94%
Similar papers in this journal
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays 96%
- The unmutated common ancestor of Gp41 conformational epitope targeting variable heavy chain 1-02 utilizing antibodies maintains antibody dependent cell cytotoxicity 93%
- Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.